Reaction Details Report a problem with these data
Target
Complement factor D
Ligand
BDBM340237
Substrate
n/a
Meas. Tech.
Inhibition Assay
IC50
5500±n/a nM
Citation
 Wiles, JA; Phadke, AS; Wang, X; Chen, D; Hashimoto, A; Gadhachanda, VR; Pais, G; Wang, Q; Agarwal, A; Deshpande, M Compounds for treatment of complement mediated disorders US Patent  US9758537 Publication Date 9/12/2017 
Target
Name:
Complement factor D
Synonyms:
Adipsin | C3 convertase activator | CFAD_HUMAN | CFD | DF | PFD | Properdin factor D
Type:
Protein
Mol. Mass.:
27039.19
Organism:
Homo sapiens (Human)
Description:
P00746
Residue:
253
Sequence:
MHSWERLAVLVLLGAAACAAPPRGRILGGREAEAHARPYMASVQLNGAHLCGGVLVAEQWVLSAAHCLEDAADGKVQVLLGAHSLSQPEPSKRLYDVLRAVPHPDSQPDTIDHDLLLLQLSEKATLGPAVRPLPWQRVDRDVAPGTLCDVAGWGIVNHAGRRPDSLQHVLLPVLDRATCNRRTHHDGAITERLMCAESNRRDSCKGDSGGPLVCGGVLEGVVTSGSRVCGNRKKPGIYTRVASYAAWIDSVLA
  
Inhibitor
Name:
BDBM340237
Synonyms:
2-(3-acetyl-6-hydroxy- 1H-indol-1-yl)-1- ((2S,4R)-2-(5-(6- bromopyridin-2-yl)-1H- imidazol-2-yl)-4- fluoropyrrolidin-1- yl)ethanone | US9758537, Compound 40
Type:
Small organic molecule
Emp. Form.:
C24H21BrFN5O3
Mol. Mass.:
526.358
SMILES:
CC(=O)c1cn(CC(=O)N2C[C@H](F)C[C@H]2c2ncc([nH]2)-c2cccc(Br)n2)c2cc(O)ccc12 |r|
Structure:
Search PDB for entries with ligand similarity: